Your browser doesn't support javascript.
loading
Hyperbaric Oxygen as an Adjunct in the Treatment of Venous Ulcers: A Systematic Review.
Keohane, Colum; Westby, Daniel; Nolan, Fiona C; Twyford, Mark; Tawfick, Wael; Walsh, Stewart R.
Afiliación
  • Keohane C; Specialist Registrar, Vascular Surgery, National University of Ireland Galway, Galway, Ireland.
  • Westby D; Specialist Registrar, Vascular Surgery, National University of Ireland Galway, Galway, Ireland.
  • Nolan FC; Specialist Registrar, Vascular Surgery, National University of Ireland Galway, Galway, Ireland.
  • Twyford M; Specialist Registrar, Vascular Surgery, National University of Ireland Galway, Galway, Ireland.
  • Tawfick W; Clinical Lecturer, National University of Ireland Galway, Galway, Ireland.
  • Walsh SR; Professor of Vascular Surgery University Hospital Galway, and Associate Director Lambe Institute for Translational Research, National University of Ireland Galway, Galway, Ireland.
Vasc Endovascular Surg ; 57(6): 607-616, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36891617
BACKGROUND: The use of Hyperbaric Oxygen Therapy (HBOT) in diabetic wounds has been studied extensively. Even though venous insufficiency is the most common cause of lower limb ulceration, there is comparatively little evidence regarding the use of HBOT for Venous Leg Ulcers (VLU). We performed a systematic-review to evaluate and synthesise available evidence, to evaluate whether patients with VLU, when treated with HBOT, had greater rates of (i) complete VLU healing or (ii) reduction in VLU area, than controls. METHODS: In keeping with PRISMA guidelines, database searches of PubMed, Scopus and Embase was performed. After removal of duplicates, titles were screened for relevance by two authors, then abstracts, and in turn full text manuscripts. Data were extracted from relevant sources including one published abstract. Included studies were assessed for risk of bias using the Risk of Bias 2 (RoB-2) and Risk Of Bias In Nonrandomized Studies (ROBINS-I) tools. RESULTS: Six studies were included. There was significant heterogeneity across the studies, with no standard control intervention, method of outcome reporting, or duration of follow up. Two studies reported 12 week follow up results and pooled analysis of complete ulcer healing showed no statistically significant difference between HBOT and controls for the outcome of complete ulcer healing OR 1.54 (95%CI = .50-4.75) P = .4478. A similar non-signifiacnt result was seen in four studies reporting 5-6 week follow up; OR 5.39 (95%CI = .57-259.57) P = .1136. Change in VLU area was reported in all studies, and pooled standardised mean difference was 1.70 (95%CI = .60 to 2.79) P = .0024, indicating a statistically significant benefit of HBOT in reducing ulcer area. CONCLUSION: Existing evidence suggests that HBOT does not significantly affect complete healing of VLU. There is a statistically significant benefit in terms of reducing ulcer size, though in the absence of ulcer healing the clinical significance of this is not established. Current evidence does not justify widespread use of HBOT for VLU.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Varicosa / Oxigenoterapia Hiperbárica Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Vasc Endovascular Surg Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Úlcera Varicosa / Oxigenoterapia Hiperbárica Tipo de estudio: Guideline / Systematic_reviews Límite: Humans Idioma: En Revista: Vasc Endovascular Surg Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irlanda Pais de publicación: Estados Unidos